Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-92,100
Closed -$7.29M 1626
2025
Q2
$7.29M Buy
92,100
+12,500
+16% +$994K 0.28% 87
2025
Q1
$7.14M Buy
79,600
+30,200
+61% +$2.82M 0.29% 89
2024
Q4
$4.91M Buy
49,400
+3,000
+6% +$309K 0.18% 150
2024
Q3
$5.27M Buy
46,400
+42,100
+979% +$5M 0.18% 145
2024
Q2
$532K Buy
4,300
+1,500
+54% +$193K 0.02% 661
2024
Q1
$369K Buy
+2,800
New +$345K 0.01% 821

Other funds holding MRK

Point72 (DIFC)'s MRK Position: Q3 2025 in Review

Point72 (DIFC) increased its Merck (MRK) stake by 1,638% in Q3 2025, buying an estimated $540K and bringing the position to 6,951 shares worth $583K. The position accounts for 0.04% of the portfolio, ranked #253.

Point72 (DIFC) first reported a position in MRK in Q1 2024 and has held it in 6 quarters since. The position peaked at $16.4M in Q1 2024. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Point72 (DIFC) held 6,951 shares of Merck worth $583K as of Q3 2025.
  • Point72 (DIFC) bought 6,551 Merck shares in Q3 2025, an estimated $540K.
  • Merck made up 0.04% of Point72 (DIFC)'s portfolio in Q3 2025, its #253 holding.
  • Point72 (DIFC) first reported a position in Merck in Q1 2024 and has held it in 6 quarters since.
  • Point72 (DIFC)'s Merck position peaked at $16.4M in Q1 2024.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.